Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Retrieved from Xie, Z., Hu, J., Gu, H., et al
Depending on the intended site of action and nature of the gene-editing, the outcome of such treatment could differ drastically from the transient effects on both IgG and albumin achieved by first-generation FcRn antagonists
Additional Resources: Gaby, A
Most studies have been conducted in rodent models, and while results are overwhelmingly positive, we cant yet predict how chronic or high-dose use will affect humans over time
2013;1830(8):411729 Sands JM, Bichet DG, American College of Physicians, American Physiological Society
US$ 27.04
US$ 28.57
:max_bytes(150000):strip_icc()/not-eating-signs-symptoms-5201896_final-c41f6a10844343059195cfb13e561098.jpg)
US$ 20.68
